GASTROINTESTINAL CANCERS
Clinical trials for GASTROINTESTINAL CANCERS explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL CANCERS trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on metastatic tumors in new trial
Disease control Recruiting nowThis phase 2 trial tests whether a patient's own white blood cells, genetically modified in a lab to recognize and attack their specific tumor mutations, can shrink metastatic cancers. Participants include people with several advanced solid tumors or multiple myeloma who have exh…
Matched conditions: GASTROINTESTINAL CANCERS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for stomach and bowel cancers: experimental drug Rina-S enters Mid-Stage trial
Disease control Recruiting nowThis Phase 2 trial is testing a new drug called Rina-S (rinatabart sesutecan) in about 160 people with advanced gastrointestinal cancers that have spread or cannot be removed. The drug is given alone through an IV, and everyone receives it—no placebo. The study will check if the …
Matched conditions: GASTROINTESTINAL CANCERS
Phase: PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Glow-in-the-Dark dye helps surgeons spot hidden cancer
Diagnosis Recruiting nowThis study tests a dye called CYTALUX (pafolacianine) that attaches to cancer cells and glows under a special camera during surgery. About 50 adults with certain cancers (like esophageal, pancreatic, or gynecologic) will get the dye before surgery. The goal is to see if the glowi…
Matched conditions: GASTROINTESTINAL CANCERS
Phase: PHASE2 • Sponsor: John Waters • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
Tailored training may boost healthy living in GI cancer survivors
Symptom relief Recruiting nowThis study tests whether personalized self-management training helps people with gastrointestinal cancer adopt healthier habits like better diet and more exercise. 120 participants will be randomly assigned to either personalized or standard training for 6 weeks. The goal is to s…
Matched conditions: GASTROINTESTINAL CANCERS
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Which painkiller combo works best for cancer surgery? new trial aims to find out
Symptom relief Recruiting nowThis study compares three routine pain control methods used during minimally invasive cancer surgery: a nerve block plus local anesthetic, nerve block alone, or local anesthetic alone. About 48 adults having surgery for various cancers will be randomly assigned to one of the thre…
Matched conditions: GASTROINTESTINAL CANCERS
Phase: NA • Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Symptom relief
Last updated Jun 26, 2026 17:48 UTC
-
New scanner could sharpen cancer radiation treatment
Knowledge-focused Recruiting nowThis study tests a new type of CT scanner called HyperSight, designed to produce clearer images during radiation therapy for cancer. About 50 adults with various cancers will receive their daily radiation using both the new and standard imaging. Researchers will compare image qua…
Matched conditions: GASTROINTESTINAL CANCERS
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC